Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease

BACKGROUND: Treatment of retinopathy of prematurity (ROP) stage 3 plus with bevacizumab is still very controversial. We report the outcome of 6 eyes of 4 premature infants with ROP stage 3 plus disease treated with ranibizumab monotherapy. METHODS: Six eyes of 4 premature infants with threshold ROP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Ophthalmol
Main Authors: Menke, Marcel N, Framme, Carsten, Nelle, Mathias, Berger, Markus R, Sturm, Veit, Wolf, Sebastian
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365803/
https://ncbi.nlm.nih.gov/pubmed/25886603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0001-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados